HIV Treatment Medication – Biktarvy, Dovato, Acriptega, Kocitaf

HIV Medication – Advanced Treatment Options

Access proven HIV medications for treatment and prevention. Our selection includes the latest HIV therapies designed to provide effective viral suppression and prevention protection.

Available HIV Medications

Biktarvy (Bictegravir/Tenofovir Alafenamide/Emtricitabine)

• Type: Complete HIV treatment and PrEP
• Mechanism: INSTI + dual NRTI combination
• Dosing: One tablet once daily
• Benefits: High barrier to resistance, excellent tolerability
• Monitoring: Regular blood work required

Kocitaf (Generic Tenofovir/Emtricitabine)

• Type: HIV treatment component and PrEP
• Mechanism: Dual nucleoside reverse transcriptase inhibitor
• Dosing: One tablet once daily
• Benefits: Cost-effective, well-established safety profile
• Monitoring: Kidney function monitoring essential

Acriptega (Dolutegravir/Tenofovir/Lamivudine)

• Type: Complete HIV treatment regimen
• Mechanism: INSTI + dual NRTI fixed-dose combination
• Dosing: One tablet once daily
• Benefits: High efficacy, low drug interaction potential
• Monitoring: Baseline and ongoing laboratory monitoring

Dovato (Dolutegravir/Lamivudine)

• Type: Two-drug HIV treatment regimen
• Mechanism: INSTI + NRTI dual therapy
• Dosing: One tablet once daily
• Benefits: Reduced drug exposure, fewer side effects
• Monitoring: Viral load and resistance testing

Medication Categories

HIV Treatment

Complete regimens for viral suppression in HIV-positive individuals

PrEP Prevention

Pre-exposure prophylaxis for HIV prevention in high-risk individuals

Fixed-Dose Combinations

Complete treatment in single daily tablets for improved adherence

Generic Options

Cost-effective alternatives with proven bioequivalence

Drug Class Information

Integrase Strand Transfer Inhibitors (INSTIs)

Modern HIV medications that block the integrase enzyme, preventing HIV from inserting its genetic material into host cells. INSTIs like dolutegravir and bictegravir offer high efficacy with minimal drug interactions.

Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Foundational HIV medications that block reverse transcriptase enzyme. Tenofovir and emtricitabine combinations provide robust activity against HIV while maintaining good tolerability profiles.

Fixed-Dose Combinations

Single tablets containing multiple active ingredients, designed to simplify dosing regimens and improve medication adherence for optimal treatment outcomes.

Important Medication Information

• All HIV medications require valid prescription from licensed physician
• Regular laboratory monitoring mandatory for all HIV treatments
• Drug interactions must be evaluated before starting therapy
• Kidney and liver function monitoring required for all patients
• Adherence to prescribed dosing schedule is critical for efficacy
• Do not discontinue therapy without medical supervision

Key Benefits of Modern HIV Therapy

High Efficacy

Modern HIV medications achieve undetectable viral loads in over 95% of patients

Simplified Dosing

Once-daily single tablet regimens improve convenience and adherence

Minimal Side Effects

Latest generation medications have significantly improved tolerability profiles

Drug Interaction Safety

Modern INSTIs have fewer drug interactions than older HIV medications

Storage and Handling

• Store at room temperature (20-25°C)
• Keep in original container to protect from moisture
• Do not store in bathroom or areas with high humidity
• Keep out of reach of children
• Do not remove desiccant packets from bottles
• Check expiration dates regularly

Prescription Required

All HIV medications require valid prescription. Ensure proper medical evaluation and monitoring for safe, effective treatment.